Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CLOV | Soares Karen | Chief Legal Officer | 08/12/2026 | Zuteilung | — | 108,695 | — | Form 4 |
| CLOV | Thornton Joseph Clay | Interim CFO | 08/12/2026 | Zuteilung | — | 54,347 | — | Form 4 |
| CLBT | Hogan Thomas E. | Chief Executive Officer | 08/11/2026 | Zuteilung | — | 339,484 | — | Form 4 |
| CLNE | Corbus Barclay | PRESIDENT AND CEO | 08/10/2026 | Kauf | 1.62 | 25,000 | 40,500 | Form 4 |
| CLOV | Toy Andrew | Chief Executive Officer | 08/10/2026 | Verkauf | 4.65 | 87,798 | 408,261 | Form 4 |
| CLBK | Kemly Thomas J. | President & CEO | 08/07/2026 | Zuteilung | 10.84 | 171 | 1,854 | Form 4 |
| CLBK | Klimowich John | SEVP & Chief Risk Officer | 08/07/2026 | Zuteilung | 10.84 | 63 | 683 | Form 4 |
| CLBK | Holland Noel R. | Director | 08/07/2026 | Zuteilung | 10.84 | 16 | 173 | Form 4 |
| CLVT | Cornick Kenneth L. | Director | 08/07/2026 | Kauf | 1.85 | 250,000 | 462,500 | Form 4 |
| CLVT | Cornick Kenneth L. | Director | 08/06/2026 | Kauf | 1.86 | 650,000 | 1,209,000 | Form 4 |
| CL | Cahill John T | Director | 08/06/2026 | Verkauf | 93.37 | 4,170 | 389,358 | Form 4 |
| CL | Cahill John T | Director | 08/06/2026 | Optionsausübung | 71.56 | 4,170 | 298,405 | Form 4 |
| CLMB | Bass Charles Edward | Chief Alliance Officer | 08/05/2026 | Steuer-Abgabe | 26.78 | 746 | 19,978 | Form 4 |
| CLMB | Sullivan Matthew M | Chief Financial Officer | 08/05/2026 | Steuer-Abgabe | 26.78 | 646 | 17,300 | Form 4 |
| CLMB | Foster Dale Richard | Chief Executive Officer | 08/05/2026 | Steuer-Abgabe | 26.78 | 1,015 | 27,182 | Form 4 |
| CLMB | Popovich Timothy | Chief Operating Officer | 08/05/2026 | Steuer-Abgabe | 26.78 | 222 | 5,945 | Form 4 |
| CL | Wallace Noel R. | Chairman, President & CEO | 08/05/2026 | Verkauf | 92.52 | 161,021 | 14,897,904 | Form 4 |
| CL | Wallace Noel R. | Chairman, President & CEO | 08/05/2026 | Optionsausübung | 72.29 | 161,021 | 11,640,208 | Form 4 |
| CL | Wallace Noel R. | Chairman, President & CEO | 08/04/2026 | Verkauf | 91.92 | 161,021 | 14,800,712 | Form 4 |
| CL | Wallace Noel R. | Chairman, President & CEO | 08/04/2026 | Optionsausübung | 72.29 | 161,021 | 11,640,208 | Form 4 |
| CLVT | Snyder Andrew Miles | Director | 08/03/2026 | Verkauf | 1.94 | 2,002,242 | 3,884,349 | Form 4 |
| CLVT | Snyder Andrew Miles | Director | 08/03/2026 | Verkauf | 1.94 | 176,674 | 342,748 | Form 4 |
| CLVT | Snyder Andrew Miles | Director | 08/03/2026 | Verkauf | 1.94 | 310,702 | 602,762 | Form 4 |
| CLH | Robertson Andrea | Director | 08/03/2026 | Verkauf | 314.01 | 789 | 247,754 | Form 4 |
| CLB | Teo Sow Hang | CAO & Treasurer | 08/01/2026 | Optionsausübung | — | 200 | — | Form 4 |
| CLB | Teo Sow Hang | CAO & Treasurer | 08/01/2026 | Steuer-Abgabe | 10.64 | 90 | 958 | Form 4 |
| CLB | Teo Sow Hang | CAO & Treasurer | 08/01/2026 | Optionsausübung | — | 240 | — | Form 4 |
| CLB | Teo Sow Hang | CAO & Treasurer | 08/01/2026 | Steuer-Abgabe | 10.64 | 108 | 1,149 | Form 4 |
| CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 08/01/2026 | Optionsausübung | — | 250 | — | Form 4 |
| CLB | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | 08/01/2026 | Steuer-Abgabe | 10.64 | 99 | 1,053 | Form 4 |
| CLB | Bruno Lawrence | Chairman and CEO | 07/31/2026 | Kauf | 10.78 | 5,000 | 53,900 | Form 4 |
| CLMB | Bell Peter W | Director | 07/28/2026 | Zuteilung | — | 5,855 | — | Form 4 |
| CLBK | Kemly Thomas J. | President & CEO | 07/24/2026 | Zuteilung | 10.88 | 171 | 1,860 | Form 4 |
| CLBK | Klimowich John | SEVP & Chief Risk Officer | 07/24/2026 | Zuteilung | 10.88 | 63 | 685 | Form 4 |
| CLX | Barton Nina | EVP-Chief Growth & Strategy Of | 07/22/2026 | Steuer-Abgabe | 95.69 | 1,681 | 160,855 | Form 4 |
| CLOV | Soares Karen | Chief Legal Officer | 07/20/2026 | Verkauf | 4.51 | 51,700 | 233,167 | Form 4 |
| CLH | Mckim Alan S | EXEC CHAIR, CTO. | 07/17/2026 | Steuer-Abgabe | 310.58 | 1,265 | 392,884 | Form 4 |
| CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | 07/17/2026 | Verkauf | 4.53 | 4,839 | 21,921 | Form 4 |
| CLX | Hyder Chris T | EVP-Chief Operating Officer | 07/15/2026 | Steuer-Abgabe | 94.75 | 277 | 26,246 | Form 4 |
| CLOV | Toy Andrew | Chief Executive Officer | 07/15/2026 | Verkauf | 4.67 | 62,711 | 292,860 | Form 4 |
| CLOV | Wai Conrad | CEO, Counterpart Health | 07/15/2026 | Verkauf | 4.67 | 24,215 | 113,084 | Form 4 |
| CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | 07/15/2026 | Verkauf | 4.67 | 13,119 | 61,266 | Form 4 |
| CLOV | Soares Karen | Chief Legal Officer | 07/15/2026 | Verkauf | 4.67 | 10,519 | 49,124 | Form 4 |
| CLOV | Thornton Joseph Clay | Interim CFO | 07/15/2026 | Verkauf | 4.67 | 4,630 | 21,622 | Form 4 |
| CLBK | Kemly Thomas J. | President & CEO | 07/10/2026 | Zuteilung | 21.25 | 87 | 1,849 | Form 4 |
| CLBK | Klimowich John | SEVP & Chief Risk Officer | 07/10/2026 | Zuteilung | 21.25 | 32 | 680 | Form 4 |
| CLBK | Holland Noel R. | Director | 07/10/2026 | Zuteilung | 21.25 | 8 | 170 | Form 4 |
| CLMT | Boss John G. | Director | 07/09/2026 | Steuer-Abgabe | — | 2,827 | — | Form 4 |
| CLMT | Boss John G. | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Mawer Stephen P | Director | 07/09/2026 | Steuer-Abgabe | — | 5,512 | — | Form 4 |
| CLMT | Mawer Stephen P | Director | 07/09/2026 | Optionsausübung | — | 13,780 | — | Form 4 |
| CLMT | Raymond Paul C | Director | 07/09/2026 | Steuer-Abgabe | — | 2,827 | — | Form 4 |
| CLMT | Raymond Paul C | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Sajkowski Daniel J | Director | 07/09/2026 | Steuer-Abgabe | — | 2,827 | — | Form 4 |
| CLMT | Sajkowski Daniel J | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Schumacher Amy M | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Quintana Julio M | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Narwold Karen G | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLMT | Twitchell Karen A. | Director | 07/09/2026 | Optionsausübung | — | 7,067 | — | Form 4 |
| CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | 07/08/2026 | Verkauf | 4.68 | 2,384 | 11,157 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).